Accumulating evidence suggested that miR-138 regulated cancer cells proliferation by inhibiting target genes expression that was implicated in some pro-cancer signaling pathways, including insulin-like growth factor (IGF), EGFR, AKT and MAPK [49–52]. The gene discussed is EGFR; the disease is cancer.